One of the fascinating storylines going into the 63rd Rolex 24 At Daytona examined just how different the 61-car grid looked to start the 2025 IMSA WeatherTech SportsCar Championship versus the end of ...

AWA and drivers Matt Bell, Orey Fidani, Lars Kern and Martin Kirchhöfer captured the GT Daytona (GTD) victory in the Rolex 24 ...

Both feature a similar base of regulations, with a few tweaks, and both can compete in either WEC or IMSA. Le Mans Daytona ... but the No. 91 Trackhouse Corvette is expected to be quick thanks ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

However, like its predecessors, the C8.R Corvette has also enjoyed some tremendous success on that track – in fact, the endurance racer debuted in the in the GTLM class of the IMSA WeatherTech ...

Get ready for the 2025 IMSA WeatherTech SportsCar Championship with your FREE digital season preview magazine from RACER.

Copyright 2025 The Associated Press. All Rights Reserved. Tech executive and part-time racer Ben Sloss shows off the helmet designed by his wife Christine, Thursday ...

and Motul Petit Le Mans with the works-supported No. 4 Chevrolet Corvette Z06 GT3.R this season alongside full-season drivers Tommy Milner and Nicky Catsburg after a partial 2024 IMSA campaign ...

1999 – No. 2 Corvette C5-R: Ron Fellows/Chris Kneifel/John Paul Jr. – 3rd in GTS No. 4 Corvette C5-R: Andy Pilgrim/Scott Sharp/John Heinricy – 12th in GTS 2000 – No. 3 Corvette C5-R ...

A transcript will be provided following the press conference. 1999 – No. 2 Corvette C5-R: Ron Fellows/Chris Kneifel/John Paul Jr. – 3rd in GTS No. 4 Corvette C5-R: Andy Pilgrim/Scott Sharp ...

The first 60 minutes and last two hours will air on NBC. USA, IMSA.TV and YouTube will share the middle portions. After that, IMSA, NASCAR’s sports-car cousin, will hibernate for six weeks.

IMSA-101 is under clinical development by ImmuneSensor Therapeutics and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II drugs for Hematological Tumor does not have ...